ITGA2 and breast cancer: Furthermore, using the GEPIA web tool, we found that the mRNA expression levels of ITGA2 correlated positively with PD-L1 levels in several malignant tumors, including pancreatic, liver, gastric, and breast cancers (Fig. 6d).